Glutamine and Ulcerative Colitis: What the Evidence Actually Says

Part of the wider work on long term conditions and systems navigation at The Reasonable Adjustment.

If you have ulcerative colitis and keep seeing people online selling glutamine as a gut healing cure, here is the short version.

• Glutamine is important fuel for the gut lining and some immune cells.
• In lab and animal models, it can support the intestinal barrier and tweak inflammatory signals.
• In real humans with inflammatory bowel disease, clinical trials are small, inconsistent, and do not show a reliable effect on remission or flare control.
• Major nutrition guidelines for IBD do not recommend glutamine as a standard treatment.

Glutamine is biologically interesting and might help at the edges. It is not a substitute for proper IBD treatment and it is not the miracle supplement social media implies.

What glutamine actually does in the gut

Glutamine is an amino acid that your body uses heavily in fast turnover tissues, especially the gut and immune system.

In the intestines it has three main jobs that keep coming up in the research:

• Fuel for intestinal cells. Cells lining the small and large intestine burn glutamine for energy, which helps maintain the gut barrier and repair everyday damage.
• Support for tight junctions. Glutamine influences proteins that hold intestinal cells together, so it can reduce “leakiness” of the gut lining in some experimental and clinical settings.
• Immune and oxidative stress effects. In models of colitis, glutamine can alter inflammatory signalling and improve antioxidant capacity.

A 2019 systematic review of glutamine in inflammatory bowel disease goes through this biology in detail and concludes that supplementation improves intestinal permeability and some immune markers, but with conflicting clinical results across trials. You can read it here: “Glutamine as a Therapeutic Strategy in Inflammatory Bowel Diseases” (Schanuel et al, 2019).

What the evidence shows in ulcerative colitis and IBD

Clinical trials and systematic reviews

Several trials have looked at glutamine in inflammatory bowel disease, usually as an add on to standard care. When you step back and look at the pooled data, the signal is weak.

The most blunt assessment comes from a 2021 systematic review of clinical trials in IBD patients:

• The review included randomised trials of glutamine in Crohn’s disease and ulcerative colitis, using oral, enteral, and parenteral routes.
• Across outcomes like disease activity scores, intestinal permeability, inflammatory markers, symptoms, and anthropometric measures, glutamine did not show consistent benefit compared with control treatments.

That review is open access here: “Effects of glutamine supplementation on inflammatory and nutritional markers in patients with inflammatory bowel disease” (Severo et al, 2021).

There is also a 2024 meta analysis that looked at glutamine and gut permeability in adults across different conditions, not just IBD:

• Overall, glutamine did not significantly change intestinal permeability when you pool all studies.
• A subgroup taking more than 30 g per day for less than two weeks showed a small statistical improvement in permeability, but the authors questioned how clinically meaningful that is.

You can read that paper here: “A systematic review and meta analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults” (Abbasi et al, 2024).

Older hospital based studies in severe IBD used glutamine enriched parenteral or enteral nutrition. A few showed modest improvements in nutritional markers or mucosal healing, but they were small, short, and tightly controlled. They do not translate into “take a scoop of glutamine at home and your ulcerative colitis will calm down”.

Guidelines: why your gastro probably never mentions it

The main clinical nutrition guidelines for IBD are equally unsold on glutamine.

The European Society for Clinical Nutrition and Metabolism (ESPEN) guideline on clinical nutrition in IBD sets out what nutrition strategies actually have enough evidence to be recommended. It emphasises energy, protein, and micronutrient sufficiency, and recognises that malnutrition, low bone density, and growth issues in children matter. It does not recommend routine glutamine supplementation:

• The 2017 scientific guideline is here: “ESPEN guideline: Clinical nutrition in inflammatory bowel disease” (Forbes et al, 2017).
• The updated 2023 guideline, which revisits the evidence and extends the recommendations, is here: “ESPEN guideline on Clinical Nutrition in inflammatory bowel disease” (Bischoff et al, 2023).

Both documents place glutamine in the “interesting but not proven” category, so it stays off the standard treatment list.

Where glutamine might still matter

Even if it is not a core IBD treatment, there are a few situations where glutamine might provide a small, realistic benefit.

Barrier support and “leaky gut” style problems

The 2024 gut permeability meta analysis mentioned above is worth paying attention to. In adults with various conditions, short term oral glutamine at higher doses nudged permeability markers in the right direction, especially when given at more than 30 g per day for less than two weeks.

That fits with other work looking at barrier function and epithelial integrity. The problem is that better permeability on a lab test has not yet translated into robust improvements in real world ulcerative colitis outcomes like fewer flares or better quality of life scores.

Acute gut injury and hospital settings

Some of the clearest human benefits for glutamine are in acute gut injury settings that sit next to IBD rather than inside it.

For example, a 2025 trial in people with external duodenal fistulas found that low dose oral glutamine improved intestinal permeability and supported spontaneous fistula closure as part of a broader care plan. You can read the details here: “Oral low dose of glutamine improved the spontaneous closure of external duodenal fistula” (Huang et al, 2025).

Other surgical trials suggest glutamine enriched feeds can reduce some inflammatory markers after abdominal operations, although results are mixed.

For someone with ulcerative colitis, that suggests a narrow role. In severe flares that land you in hospital, or in post operative nutrition, the team might consider glutamine inside a controlled feeding plan. That is very different from a self prescribed supplement in day to day life.

IBS overlay and functional gut problems

Glutamine has also been tested in irritable bowel syndrome and other functional gut conditions.

A randomised trial combined a low FODMAP diet with glutamine in IBS and found that adding 15 g per day of glutamine improved symptom scores more than diet alone. The paper is here: “Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management” (Rastgoo et al, 2021).

A 2024 review on dietary management of IBS in The Lancet Gastroenterology also notes glutamine as a possible adjunct, but stresses that data are still limited: “Dietary management of irritable bowel syndrome” (Whelan et al, 2024).

If you have ulcerative colitis plus an IBS overlay, glutamine might help the IBS type sensitivity and loose stool side of things more than the inflammatory colitis itself. That is still a maybe, not a guarantee.

If you are considering a glutamine trial

This is general information, not personal medical advice, but specifically what the research has actually looked at.

In human trials you mainly see:

• Form. L glutamine powder mixed with water or juice for oral use. Hospital work sometimes uses dipeptides such as alanyl glutamine in enteral feeds or intravenous solutions.
• Dose. Intestinal permeability trials often use around 30 g per day in divided doses for up to 2 weeks. IBD trials use a wider range, with no clear “best” dose established.
• Duration. Short, focused interventions are more common than open ended daily supplementation.

That is what researchers have done, not a suggested protocol for you. There is also some experimental work hinting that extremely high glutamine loads could worsen inflammation in some models, which is another reason not to chase huge doses without supervision.

Safety and red flags

In many otherwise healthy adults, modest doses of glutamine appear well tolerated. There are still situations where you should be cautious or avoid it outright.

• Kidney or liver disease. Glutamine metabolism is tied into ammonia handling. If you have significant renal or hepatic impairment, this is one to clear with a specialist first.
• Severe active disease or recent surgery. In severe flares, recent abdominal operations, or fistulas, any supplement should be coordinated with your gastroenterologist, surgeon, or IBD team.
• Complex medication regimens. If you are on chemotherapy, certain anticonvulsants, or other drugs with narrow safety windows, it is sensible to check for potential interactions.

Common side effects reported in studies are mainly digestive, for example bloating or mild discomfort.

How glutamine really fits into life with ulcerative colitis

Putting the pieces together, glutamine sits in an awkward middle ground.

• It has a plausible mechanism for supporting the gut lining and modulating inflammation.
• It shows modest benefits in some acute gut injury and surgical settings.
• In ulcerative colitis and Crohn’s disease, human trials are not strong enough to earn it a secure place in guidelines or standard care.

That makes it a possible short term adjunct for some people, especially around barrier repair, not a core treatment nor a licence to ignore medication.

Sources and further reading

• Schanuel et al, 2019, “Glutamine as a Therapeutic Strategy in Inflammatory Bowel Diseases” – systematic review of glutamine in IBD, focusing on mechanisms and clinical trials.
• Severo et al, 2021, “Effects of glutamine supplementation on inflammatory and nutritional markers in patients with inflammatory bowel disease” – systematic review of clinical trials in IBD.
• Abbasi et al, 2024, “A systematic review and meta analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults” – meta analysis on glutamine and gut permeability.
• Forbes et al, 2017, “ESPEN guideline: Clinical nutrition in inflammatory bowel disease” and Bischoff et al, 2023, “ESPEN guideline on Clinical Nutrition in inflammatory bowel disease” – guideline documents that frame the role of nutrition and supplements in IBD.
• Huang et al, 2025, “Oral low dose of glutamine improved the spontaneous closure of external duodenal fistula” – acute gut injury context where glutamine shows clearer benefit.
• Rastgoo et al, 2021, “Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management” – IBS trial that often gets cited in gut health discussions.